Charles Schwab Investment Management Inc Apellis Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $601 Billion
  • Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 647,082 shares of APLS stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
647,082
Previous 989,143 34.58%
Holding current value
$13.2 Million
Previous $17.1 Million 14.48%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
SELL
$17.42 - $28.65 $5.96 Million - $9.8 Million
-342,061 Reduced 34.58%
647,082 $14.6 Million
Q2 2025

Aug 12, 2025
BUY
$16.36 - $23.0 $403,175 - $566,812
24,644 Added 2.56%
989,143 $17.1 Million
Q1 2025

Sep 15, 2025
SELL
$21.87 - $34.63 $538,964 - $853,421
-24,644 Reduced 2.49%
964,499 $21.1 Million
Q1 2025

May 09, 2025
SELL
$21.87 - $34.63 $705,285 - $1.12 Million
-32,249 Reduced 3.24%
964,499 $21.1 Million
Q4 2024

Feb 06, 2025
BUY
$26.18 - $35.42 $1.06 Million - $1.43 Million
40,386 Added 4.22%
996,748 $31.8 Million
Q3 2024

Nov 12, 2024
BUY
$28.84 - $41.15 $269,019 - $383,847
9,328 Added 0.98%
956,362 $27.6 Million
Q2 2024

Aug 12, 2024
BUY
$38.07 - $59.71 $855,509 - $1.34 Million
22,472 Added 2.43%
947,034 $36.3 Million
Q1 2024

May 08, 2024
BUY
$55.39 - $72.47 $1.12 Million - $1.46 Million
20,153 Added 2.23%
924,562 $54.3 Million
Q4 2023

Feb 06, 2024
BUY
$37.14 - $64.82 $930,431 - $1.62 Million
25,052 Added 2.85%
904,409 $54.1 Million
Q3 2023

Nov 08, 2023
BUY
$23.65 - $89.22 $1.2 Million - $4.54 Million
50,835 Added 6.14%
879,357 $33.5 Million
Q2 2023

Aug 09, 2023
SELL
$76.68 - $93.31 $11.9 Million - $14.5 Million
-154,987 Reduced 15.76%
828,522 $75.5 Million
Q1 2023

May 11, 2023
BUY
$46.59 - $66.96 $27,115 - $38,970
582 Added 0.06%
983,509 $64.9 Million
Q4 2022

Feb 13, 2023
BUY
$43.24 - $61.04 $1.48 Million - $2.09 Million
34,168 Added 3.6%
982,927 $50.8 Million
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $12.1 Million - $18.8 Million
270,358 Added 39.85%
948,759 $64.8 Million
Q2 2022

Aug 15, 2022
BUY
$35.07 - $59.21 $809,871 - $1.37 Million
23,093 Added 3.52%
678,401 $30.7 Million
Q1 2022

May 13, 2022
BUY
$35.46 - $54.12 $2.25 Million - $3.43 Million
63,394 Added 10.71%
655,308 $33.3 Million
Q4 2021

Feb 11, 2022
BUY
$30.74 - $49.16 $2.25 Million - $3.59 Million
73,103 Added 14.09%
591,914 $28 Million
Q3 2021

Nov 16, 2021
BUY
$31.4 - $69.84 $3.14 Million - $6.99 Million
100,145 Added 23.92%
518,811 $17.1 Million
Q2 2021

Aug 16, 2021
BUY
$40.9 - $64.9 $594,645 - $943,581
14,539 Added 3.6%
418,666 $26.5 Million
Q1 2021

May 17, 2021
BUY
$40.8 - $57.39 $1.17 Million - $1.64 Million
28,628 Added 7.62%
404,127 $17.3 Million
Q4 2020

Feb 16, 2021
BUY
$30.79 - $57.2 $186,926 - $347,261
6,071 Added 1.64%
375,499 $21.5 Million
Q3 2020

Nov 13, 2020
BUY
$25.89 - $33.65 $184,828 - $240,227
7,139 Added 1.97%
369,428 $11.1 Million
Q2 2020

Aug 14, 2020
BUY
$24.8 - $38.49 $773,908 - $1.2 Million
31,206 Added 9.43%
362,289 $11.8 Million
Q1 2020

May 15, 2020
BUY
$17.91 - $44.33 $1.1 Million - $2.73 Million
61,670 Added 22.89%
331,083 $8.87 Million
Q4 2019

Feb 07, 2020
BUY
$22.1 - $30.8 $184,070 - $256,533
8,329 Added 3.19%
269,413 $8.25 Million
Q3 2019

Nov 08, 2019
BUY
$24.09 - $32.18 $376,093 - $502,394
15,612 Added 6.36%
261,084 $6.29 Million
Q2 2019

Aug 09, 2019
BUY
$18.0 - $25.34 $613,152 - $863,181
34,064 Added 16.11%
245,472 $6.22 Million
Q1 2019

May 14, 2019
BUY
$12.81 - $19.82 $242,992 - $375,965
18,969 Added 9.86%
211,408 $4.12 Million
Q4 2018

Feb 14, 2019
SELL
$11.47 - $18.71 $1,376 - $2,245
-120 Reduced 0.06%
192,439 $2.54 Million
Q3 2018

Nov 13, 2018
BUY
$16.57 - $21.03 $337,696 - $428,591
20,380 Added 11.84%
192,559 $3.42 Million
Q2 2018

Aug 08, 2018
BUY
$19.63 - $30.0 $2.54 Million - $3.88 Million
129,488 Added 303.31%
172,179 $3.79 Million
Q1 2018

May 07, 2018
BUY
$14.01 - $26.02 $41,315 - $76,732
2,949 Added 7.42%
42,691 $944,000
Q4 2017

Jan 17, 2018
BUY
$12.71 - $21.7 $505,120 - $862,401
39,742
39,742 $863,000

Others Institutions Holding APLS

# of Institutions
330
Shares Held
124M
Call Options Held
4.15M
Put Options Held
769K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.23B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email